A reduced-dose steroid regimen in high-risk IgaN may offer the best balance of risks vs benefits, an investigator stated.
In a study of patients with stage 4 chronic kidney disease and poorly controlled blood pressure, chlorthalidone significantly decreased systolic blood pressure compared with placebo.
In 2020, nearly 72% of patients in a US study initiated dialysis at an eGFR of 10 mL/min/1.73 m2 or higher.
Lower baseline kidney function and proton pump inhibitor use increased the risk for acute kidney injury associated with immune checkpoint inhibitor therapy.
Metabolic acidosis was defined as serum bicarbonate values of 12 or higher but less than 22 mEq/L.
Receipt of any RBC transfusion was significantly associated with increased risk for venous thromboembolism.
Multimorbidity is more common in patients with chronic kidney disease (CKD) than any other long-term condition, according to investigators.
SGLT2 inhibitors are associated with an initial dip in eGFR, so nephrologists need to monitor kidney function.
Elevated parathyroid hormone has been reported as a potential risk factor for cognitive impairment.
Patients who survive the first 30 days of COVID-19 are more likely to have acute kidney injury and chronic kidney disease compared with those who do not contract the disease.
Data suggest that higher oxalate levels increase the risk for incident CKD.
Previous studies indicate that selenium and selenoproteins are involved in erythropoiesis.
Daprodustat is as effective as erythropoiesis-stimulating agents in treating anemia in patients with dialysis-dependent and nondialysis-dependent chronic kidney disease.
Obesity rates in glomerular disease have multiplied more than 10-fold over the last 40 years.
Nephrologists are in a prime position to identify HCV-infected patients and refer them for treatment with DAAs, according to investigators.
Offspring exposed to hypertensive disorders of pregnancy in gestation and those with maternal hypertension should be considered an elevated risk group, investigators concluded.
Serum bicarbonate levels less than 20 mEq/L are associated with increased risk for infection-related hospitalization.
Nationally standardized treatment algorithms for hyperkalemia should be developed, according to investigators.
Plasma levels of tumor necrosis factor receptors 1 and 2 are robust predictors of major adverse kidney events.
Long-term aspirin use by patients with nondialysis chronic kidney disease is associated with a lower risk for adverse kidney outcomes and death, a study found.